Study Name Principal Investigator
(ALPINE2) Randomized, Double-Blind, Phase 3B Trial to Evaluate the Safety and Efficacy of 2 Treatment Regimens of Aztreonam 75 mg Powder and Solvent for Nebulizer Solution / Aztreonam for Inhalation Solution (AZLI) in Pediatric Subjects with Cystic Fibrosis (CF) and New Onset Respiratory Tract Pseudomonas aeruginosa (PA) Infection/Colonization [Aztreonam Lysine for Pseudomonas INfection Eradication 2 (ALPINE 2) Study] McKie, Kathleen
(Savara) A Phase III, randomized, double-blind, placebo-controlled study of AeroVanc for the treatment of persistent methicillin-resistant Staphylococcus aureus lung infection in cystic fibrosis patients McKie, Kathleen
(STOP 2) Standardized Treatment of Pulmonary Exacerbations II Forseen, Caralee
(The PROMISE Study) A prospective study to evaluate biological and clinical effects of significantly corrected CFTR function Taskar, Varsha
A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of VX-445 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation Forseen, Caralee
Acceptance and Commitment Therapy vs. Supportive Psychotherapy with Cystic Fibrosis Patients Drescher, Christopher
Comparison of audiologic screening modalities in patients with cystic fibrosis Koehn, Heather
Georgia CF Center Longitudinal Phenotyping (CFP30-P) Harris, Ryan
Role of blood flow on artery function and exercise capacity in cystic fibrosis (CF-FLOW) Harris, Ryan